Working... Menu

Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01857544
Recruitment Status : Unknown
Verified October 2014 by Tennessee Retina.
Recruitment status was:  Active, not recruiting
First Posted : May 20, 2013
Last Update Posted : October 29, 2014
Regeneron Pharmaceuticals
Information provided by (Responsible Party):
Tennessee Retina

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : January 2016
  Estimated Study Completion Date : March 2016